Sirolimus-Eluting Stents vs Brachytherapy for restenosis [5]

JAMA

Volumn 296, Issue 15, 2006, Pages 1837-1838

  Alfonso, Fernando ^a   Sabate, Manel ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; RAPAMYCIN;

BRACHYTHERAPY; CLINICAL TRIAL; DRUG ELUTING STENT; HUMAN; IRRADIATION; LETTER; PRIORITY JOURNAL; RECURRENT DISEASE; RESTENOSIS; TREATMENT DURATION;

EID: 33750047220     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.15.1837-c     Document Type: Letter

References (2)

1. Holmes DR Jr, Teirstein P, Satler L, et al; for the SISR investigators. Sirolimuseluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA. 2006;295:1264-1273.
2. Sabate M, Costa MA, Kozuma K, et al. Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation. 2000;101:2467-2471.